Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

Detalles Bibliográficos
Main Authors:	Mcmurray, J, Laakso, M, Standl, E, Tognoni, G, Holman, R, Giles, T, Martinez, F, Thomas, L, Haffner, S, Califf, R
Formato:	Journal article
Publicado:	2011

Títulos similares